Privia Health Group (PRVA) director awarded 8,463 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Morris Matthew Shawn reported acquisition or exercise transactions in this Form 4 filing.

Privia Health Group director Matthew Shawn Morris reported an equity award. On May 20, 2026, he received 8,463 restricted stock units under the company’s 2021 Omnibus Incentive Plan at a grant price of $0.00 per share, increasing his direct holdings to 76,651 common shares.

The restricted stock units will vest on the earlier of the day immediately preceding Privia Health Group’s 2027 annual meeting of stockholders or the first anniversary of the grant date. Separate holding entries show 11,998 common shares held indirectly by a trust and 12,487 common shares held indirectly by Emerald Family, LLC.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Morris Matthew Shawn

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	8,463	$0.00	--
holding	Common Stock, par value $0.01 per share	--	--	--
holding	Common Stock, par value $0.01 per share	--	--	--

Holdings After Transaction: Common Stock, par value $0.01 per share — 76,651 shares (Direct, null); Common Stock, par value $0.01 per share — 12,487 shares (Indirect, By Emerald Family, LLC)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 8,463 units Grant price: $0.00 per share Direct holdings after grant: 76,651 shares +2 more

5 metrics

RSU grant size 8,463 units Restricted stock units granted on May 20, 2026

Grant price $0.00 per share RSU award under 2021 Omnibus Incentive Plan

Direct holdings after grant 76,651 shares Common stock directly owned following the transaction

Trust indirect holdings 11,998 shares Common stock held indirectly by trust

Emerald Family, LLC holdings 12,487 shares Common stock held indirectly via Emerald Family, LLC

Key Terms

restricted stock units, 2021 Omnibus Incentive Plan, annual meeting of stockholders, indirect ownership, +1 more

5 terms

restricted stock units financial

"the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2021 Omnibus Incentive Plan financial

"received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan"

annual meeting of stockholders financial

"will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders"

indirect ownership financial

"direct_or_indirect": "I", "nature_of_ownership": "By Trust""

non-derivative financial

""transaction_type": "non-derivative""

Form 4 Insider Transactions: What Each Field Means →

05/22/2026 - 08:25 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morris Matthew Shawn

(Last)

(First)

(Middle)

PRIVIA HEALTH GROUP, INC.

950 N. GLEBE RD., SUITE 700

(Street)

ARLINGTON

VIRGINIA

22203

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Privia Health Group, Inc. [ PRVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	05/20/2026		A		8,463⁽¹⁾	A	$0	76,651	D
Common Stock, par value $0.01 per share								12,487	I	By Emerald Family, LLC
Common Stock, par value $0.01 per share								11,998	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

Remarks:

	/s/ Anita Beth Adams, as attorney-in-fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Privia Health Group (PRVA) director Matthew Shawn Morris report in this Form 4?

He reported receiving 8,463 restricted stock units of Privia Health Group common stock as an equity award. The grant was made under the 2021 Omnibus Incentive Plan at a grant price of $0.00 per share, reflecting standard director compensation.

How many restricted stock units did the Privia Health (PRVA) director receive and when do they vest?

He received 8,463 restricted stock units on May 20, 2026. These units will vest on the earlier of the day immediately preceding Privia Health Group’s 2027 annual meeting of stockholders or the first anniversary of the grant date, subject to continued service conditions.

What are Matthew Shawn Morris’s direct Privia Health (PRVA) holdings after this reported award?

After the reported award, he holds 76,651 shares of Privia Health Group common stock directly. This figure reflects his position following the grant of 8,463 restricted stock units, as shown in the Form 4 transaction table for non-derivative securities.

What indirect Privia Health Group (PRVA) holdings are associated with Matthew Shawn Morris?

The filing lists 11,998 Privia Health Group common shares held indirectly by a trust and 12,487 shares held indirectly by Emerald Family, LLC. These are classified as indirect ownership interests, separate from his directly held 76,651 common shares.

Was the Privia Health (PRVA) Form 4 transaction an open-market buy or sell?

No, it was not an open-market trade. The Form 4 shows a grant of 8,463 restricted stock units at $0.00 per share as compensation, coded as an “A” transaction, rather than a purchase or sale on the open market.